当前位置： SCI文献检索 > PLoS Neglected Tropical Diseases期刊下所有文献 > Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.

Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.

Abstract：

BACKGROUND:Current chemotherapy for Chagas disease is unsatisfactory due to its limited efficacy, particularly in the chronic phase, with frequent side effects that can lead to treatment discontinuation. Combined therapy is envisioned as an ideal approach since it may improve treatment efficacy whilst decreasing toxicity and the likelihood of resistance development. We evaluated the efficacy of posaconazole in combination with benznidazole on Trypanosoma cruzi infection in vivo. METHODS AND FINDINGS:Benznidazole and posaconazole were administered individually or in combination in an experimental acute murine infection model. Using a rapid treatment protocol for 7 days, the combined treatments were more efficacious in reducing parasitemia levels than the drugs given alone, with the effects most evident in combinations of sub-optimal doses of the drugs. Subsequently, the curative action of these drug combinations was investigated, using the same infection model and 25, 50, 75 or 100 mg/kg/day (mpk) of benznidazole in combination with 5, 10 or 20 mpk of posaconazole, given alone or concomitantly for 20 days. The effects of the combination treatments on parasitological cures were higher than the sum of such effects when the drugs were administered separately at the same doses, indicating synergistic activity. Finally, sequential therapy experiments were carried out with benznidazole or posaconazole over a short interval (10 days), followed by the second drug administered for the same period of time. It was found that the sequence of benznidazole (100 mpk) followed by posaconazole (20 mpk) provided cure rates comparable to those obtained with the full (20 days) treatments with either drug alone, and no cure was observed for the short treatments with drugs given alone. CONCLUSIONS:Our data demonstrate the importance of investigating the potential beneficial effects of combination treatments with marketed compounds, and showed that combinations of benznidazole with posaconazole have a positive interaction in murine models of Chagas disease.

journal_name

PLoS Negl Trop Dis

journal_title

PLoS neglected tropical diseases

authors

Diniz Lde F,Urbina JA,de Andrade IM,Mazzeti AL,Martins TA,Caldas IS,Talvani A,Ribeiro I,Bahia MT

doi

10.1371/journal.pntd.0002367

subject

Has Abstract

pub_date

2013-08-15 00:00:00

pages

e2367

issue

eissn

1935-2727

issn

1935-2735

pii

PNTD-D-13-00222

journal_volume

pub_type

杂志文章

在线工具

Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.